OptimizeRx received a Buy rating upgrade due to an improved growth outlook for 2027 and attractive valuation metrics. The company reported a gross margin increase to 76.5% in Q2 2026, marking five consecutive quarters of margin improvement driven by a strategic shift to higher-margin products. It reaffirmed its 2026 guidance with expected revenue between $95 million and $100 million, and adjusted EBITDA of $21 million to $25 million. The stock is valued at 8.5 times estimated 2026 EPS and 7.2 times estimated 2027 EPS, with double-digit earnings growth anticipated in 2027, making it appealing for long-term investors.
OptimizeRx's recent financial update is presented with Pluang's Health sector data as of Sep 18, 2026 17:31 WIB. Among 91 priced Health-sector US stocks on Pluang, 41 rose and 40 fell today. Notable movers include Moderna (MRNA) at USD 161.35 with a 1-day change of +2.08% and a typical hold time of 60 days, Ginkgo Bioworks Holdings (DNA) at USD 8.00 with a 1-day change of +2.04% and 100% buy order activity, and 10X Genomics (TXG) at USD 78.50 with a 1-day change of +1.99% and a typical hold time of 94 days. The most notable figure is Moderna's price at USD 161.35.
Meta's stock has rebounded nearly 20% recently, driven by optimism around its upcoming AI launch and strong ad revenue growth. Despite a sharp drop in free cash flow due to heavy capital expenditures, Meta's ad business continues to expand, with a 27...
The recently launched ACBE ETF uses autocallable structured notes to generate income, offering a different risk-return profile compared to traditional covered-call ETFs like JEPI. It aims to deliver bond-like income through equity-linked contracts bu...
Chanson International Holding reported a net income of $0.8 million for the first half of fiscal 2026, recovering from a $1.0 million loss in the same period last year. Total revenue slightly declined by 4.5% to $8.3 million, mainly due to decreased ...
Micron Technology is set to release its fiscal Q4 2026 earnings report, expected to show a record net margin of 70.7%, driven by strong demand from AI applications. While near-term optimism is high due to margin expansion, there is skepticism about t...
AGNC Investment Corp., a Mortgage REIT, offers various preferred stocks with different risk and yield profiles for income investors. While dividend coverage remains strong at nearly 13 times, par value coverage has dropped to 5.4 times due to a signi...
